EDSA
EDSA
NASDAQ · Biotechnology

Edesa Biotech Inc

$5.82
-0.04 (-0.68%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +417.9% upside
Low Target $22.58
Average Target $30.14
High Target $41.69
Current Price $5.82
Current
$5.82
Target
$30.14
$22.58 $30.14 avg $41.69
Scenario Analysis
Bear Case
$22.58
288.0%
Low target
Base Case
$30.14
+417.9%
Avg target
Bull Case
$41.69
+616.3%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$9.37
-37.9% from high
52-Week Low
$0.72
+708.3% from low
Target vs 52W High
$30.14
+221.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +18.4%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.8%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +160.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -1.8%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.1%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -28.5%